Breaking News

ProRx Pharma Expands Production to Address Drug Shortages

To bring ops to a total of 6,888 sq.-ft., tripling manufacturing capabilities and enhancing operational processes.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

ProRx Pharma, a cGMP, 503B outsourcing facility focused on providing essential compounded medications, has expanded its operations to help meet the demand for critical medications. The company specializes in manufacturing products on the FDA’s drug shortage list, offering medications to clinical centers, hospitals and pharmaceutical companies. ProRx is currently expanding its operations to a total of 6,888 sq.-ft., doubling its existing pharmaceutical and manufacturing facility. The new...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters